A detailed history of Pathstone Family Office, LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 12,819 shares of MDXG stock, worth $87,041. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,819
Holding current value
$87,041
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$6.35 - $8.16 $81,400 - $104,603
12,819 New
12,819 $93,000
Q1 2021

May 14, 2021

SELL
$8.48 - $11.28 $50,880 - $67,680
-6,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$5.32 - $10.17 $31,920 - $61,020
6,000 New
6,000 $54,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $771M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.